Drug
Pf-03715455 clinical trials
Also written PF-03715455.
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2010
How studies write it
Studies that test it under each name
Development codes
Studies by the year they started
4 studies that test it; most in 2010 (1)
| Year | Studies |
|---|---|
| 2010 | 1 |
| 2011 | 1 |
| 2014 | 1 |
| 2015 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses pf-03715455 is read from its arms, and is right about nine times in ten.
Testing it · 4
- An Evaluation Of PF-03715455 In Moderate To Severe Uncontrolled AsthmaTerminatedPhase 2PfizerNCT02219048Written as PF-03715455
- An Evaluation Of PF-03715455 In Moderate To Severe Chronic Obstructive Pulmonary DiseaseTerminatedPhase 2PfizerNCT02366637Written as PF-03715455
- Single Dose Lipopolysaccharide (LPS) Study In Healthy VolunteersCompletedPhase 1PfizerNCT01314885Written as PF-03715455
- Multiple Dose Healthy Volunteer Study of PF-03715455.CompletedPhase 1PfizerNCT01186757Written as PF-03715455
Codes
What other systems call pf-03715455 · ClinicalTrials.gg INT005987
- UNII (FDA) 0TJ631J0KPPF-03715455Confirmed NLM, Wikidata
- Wikidata Q27088311pf-03715455Confirmed NLM, Wikidata
- DrugBank DB12138One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 0TJ631J0KP | PF-03715455 | Confirmed NLM, Wikidata |
| Wikidata | Q27088311 | pf-03715455 | Confirmed NLM, Wikidata |
| DrugBank | DB12138 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.